Anavex Life Sciences earnings were -$13.0M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest AVXL earnings report on Jun 30, 2026 announced Q2 2026 earnings of $7.8M, down 246.6% from last quarter. For the last reported fiscal year 2025 ending Sep 30, 2025, AVXL reported annual earnings of -$46.4M, with 7.8% growth. The next AVXL earnings date is Nov 24, 2026.
Anavex Life Sciences Earnings Reports & History FAQ
What were Anavex Life Sciences's earnings last quarter?
On AVXL's earnings call on Aug 25, 2026, Anavex Life Sciences (NASDAQ: AVXL) reported Q2 2026 earnings per share (EPS) of $0.08, up 150% year over year. Total AVXL earnings for the quarter were $7.82 million. In the same quarter last year, Anavex Life Sciences's earnings per share (EPS) was -$0.16.
The next AVXL earnings date is Nov 24, 2026. Add AVXL to your watchlist to be reminded of Anavex Life Sciences's next earnings date.
Is Anavex Life Sciences profitable or losing money?
As of the last Anavex Life Sciences earnings report, Anavex Life Sciences is currently losing money. Anavex Life Sciences's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$13.02 million, a 72.97% decrease year over year.
What was AVXL's earnings growth in the past year?
As of Anavex Life Sciences's earnings date in Aug 25, 2026, Anavex Life Sciences's earnings has grown year over year. AVXL earnings in the past year totalled -$13.02 million.
What are Anavex Life Sciences's earnings expectations?
The current EPS estimate for Anavex Life Sciences's earnings report in Nov 24, 2026 is -$0.11.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.